window-to-japan.eu

Window to Japan

UMN Pharma and Yakult sign second joint venture agreement on joint development of biosimilars

By schmid_wordpressPosted on Posted in News

The agreement covers development of therapeutic antibodies for cancer treatment.

UMN Pharma news release, December 18, 2013

UMN Pharma and Yakult sign second joint venture agreement on joint development of biosimilars
Scroll to top